We speak to medical oncologist Narjust Duma, from the University of Wisconsin in the USA, about COVID-19 vaccination in people with cancer, discussing issues such as vaccine timing, side-effects, and key unanswered research questions.

Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman)

May 27th, 2020 24m 8s

In this Medicine Matters oncology podcast, we speak to Gary Lyman (Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, USA) about the impact of the COVID-19 outbreak on the conduct of cancer clinical trials. Find m

The UK Coronavirus Cancer Monitoring Project: What you need to know (with Lennard Lee)

May 22nd, 2020 7m 40s

Co-project leader Lennard Lee talks about the inception and development of the initiative that will provide insight into the impact of COVID-19 on people with cancer and facilitate shared learning that will benefit patient care. Find more on Me

CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes)

Apr 8th, 2020 5m 12s

Gilberto Lopes (Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA), a steering committee member of CCC19, tells us about the registry collating data on cancer patients with comorbid COVID-19 to provide an evidence b

COVID-19 and cancer: Changing practices to meet patient needs (with Beth Sandy)

Mar 31st, 2020 26m 12s

Thoracic oncology nurse practitioner Beth Sandy explains how the coronavirus pandemic is affecting cancer patient care and how strategies such as telemedicine are coming into their own. Find more on Medicine Matters oncology Image credit: Coron

Managing patients with genitourinary cancers in the time of COVID-19 (with Cora Sternberg)

Mar 25th, 2020 11m 29s

Genitourinary oncologists Cora Sternberg (Weill Cornell Medicine, New York, USA) and Axel Merseburger (University Hospital Schleswig-Holstein, Lübeck, Germany) share their experience of managing cancer patients during the COVID-19 pandemic, com

COVID-19 and cancer patient care: A lung cancer specialist’s experience (with Gilberto Lopes)

Mar 17th, 2020 5m 35s

Gilberto Lopes discusses the impact of the COVID-19 pandemic on the management of patients with lung cancer and outlines the measures being implemented to minimize the risk for patients. Find more on Medicine Matters oncology

Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)

Oct 7th, 2019 3m 41s

Colin Lindsay discusses the trial results for AMG 510 – a novel inhibitor targeting the KRAS G12C mutation – in patients with locally advanced or metastatic non-small-cell lung cancer. Find more on Medicine Matters oncology More from WCLC 2019

Understanding the relationship between the gut microbiome and immunotherapy (with Jennifer Wargo)

Jun 24th, 2019 13m 28s

Recent research has shown an association between intestinal microbiota and response to immunotherapy in the setting of various tumor types. Listen to Jennifer Wargo, from The University of Texas MD Anderson Cancer Center in Houston, USA, share

Researcher comment: COMPARE study (with Hashim Ahmed)

Jun 24th, 2019 5m 38s

Hashim Ahmed takes us through the COMPARE study – presented at NCRI 2018 – which showed that men with localized prostate cancer are willing to accept lower survival odds for a better quality of life. He outlines the key findings, the implicati

ALL and infection: Unpicking the connection (with Mel Greaves)

Jun 24th, 2019 10m 23s

Professor Mel Greaves (Institute of Cancer Research, London, UK) discusses his proposed theory for the etiology of childhood acute lymphoblastic leukemia, in which early microbial exposure plays a key role. He outlines the evidence supporting t

SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

Jun 24th, 2019 10m 46s

Advisory Board member and study author Paul Nathan, from the Mount Vernon Cancer Centre in Middlesex, UK, discusses the phase III SUMIT trial, which evaluated the addition of the MEK inhibitor selumetinib to dacarbazine in patients with metasta

Expert comment: AMPLE trial (with Fabien Maldonado)

Jun 24th, 2019 13m 29s

In this podcast, Fabien Maldonado, from Vanderbilt University Medical Center in Nashville, Tennessee, USA, provides an independent comment on the AMPLE trial, published in JAMA, which aimed to establish the more effective technique for reducing

Bevacizumab in cervical cancer (with Krishnansu Tewari)

Jun 24th, 2019 9m 26s

The phase III GOG 240 trial evaluated bevacizumab in women with advanced cervical cancer - Advisory Board member and lead investigator Krishnansu Tewari outlines the results of the final analysis in this podcast. Find more on Medicine Matters o

Rate